NCT03543813 · Interventional trial
PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL
Overall registry status Completed
Phase 1 · Phase 2
Conditions Diffuse Large B Cell Lymphoma, Esophageal Cancer, Head and Neck Cancer, Non Small Cell Lung Cancer, Solid Tumor, Adult
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory